Report Content
Chapter 1 Methodology & Scope
1.1 Definition and forecast parameters
1.1.1 Definitions
1.1.2 Methodology and forecast parameters
1.2 Data sources
1.2.1 Secondary
1.2.2 Primary
Chapter 2 Executive Summary
2.1 North America automated breast ultrasound systems industry summary, 2017 - 2028
2.1.1 Country trends
2.1.2 Product trends
2.1.3 End-use trends
Chapter 3 North America Automated Breast Ultrasound Systems Market Analysis
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028 (USD Million)
3.3 Major factor analysis
3.3.1 Drivers
3.3.1.1 Increasing prevalence of breast cancer in North America
3.3.1.2 Technological innovations by industry leaders
3.3.1.3 Limited capability of mammography in dense-breasted patients
3.3.1.4 Rising awareness regarding breast cancer and favorable government initiatives
3.3.1.5 Increasing reimbursements for breast ultrasounds in the U.S.
3.3.2 Industry pitfalls and challenges
3.3.2.1 High cost of ABUS devices in the U.S.
3.4 Analysis of COVID-19 impact on the industry
3.5 Porter’s analysis
3.6 Competition review, 2021
3.7 PEST analysis
Chapter 4 North America Automated Breast Ultrasound Systems Market, By Product
4.1 Market trends
4.2 Automated breast ultrasound systems (ABUS)
4.2.1 Market estimates and forecast, by country, 2017 - 2028 (USD Million)
4.3 Automated breast volume scanners (ABVS)
4.3.1 Market estimates and forecast, by country, 2017 - 2028 (USD Million)
4.4 Others
4.4.1 Market estimates and forecast, by country, 2017 - 2028 (USD Million)
Chapter 5 North America Automated Breast Ultrasound Systems Market, By End-use
5.1 Market trends
5.2 Hospitals
5.2.1 Market estimates and forecast, by country, 2017 - 2028 (USD Million)
5.3 Diagnostic imaging centers
5.3.1 Market estimates and forecast, by country, 2017 - 2028 (USD Million)
Chapter 6 North America Automated Breast Ultrasound Systems Market, By Country
6.1 Market trends
6.2 U.S.
6.2.1 Market size by product, 2017 - 2028 (USD Million)
6.2.2 Market size by end-use, 2017 - 2028 (USD Million)
6.3 Canada
6.3.1 Market size by product, 2017 - 2028 (USD Million)
6.3.2 Market size by end-use, 2017 - 2028 (USD Million)
Chapter 7 Company Profiles
7.1 Delphinus Medical Technologies, Inc
7.1.1 Business overview
7.1.2 Financial data
7.1.3 Product landscape
7.1.4 Strategic outlook
7.2 GE Healthcare
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.3 Hitachi Ltd.
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.4 Koninklijke Philips N.V.
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.5 Metritrack, Inc
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.6 Nova Medical Imaging Technology Co. Ltd
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.7 QView Medical Inc
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.8 Seno Medical Instruments Inc
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.9 Shantou Institute of Ultrasonic Instruments Co., Ltd
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.10 Siemens AG
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.11 SonoCine, Inc
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.12 SuperSonic Imagine
7.12.1 Business overview
7.12.2 Financial data
7.12.3 Product landscape
7.12.4 Strategic outlook
7.13 Theraclion
7.13.1 Business overview
7.13.2 Financial data
7.13.3 Product landscape
7.13.4 Strategic outlook
7.14 Canon Medical Systems
7.14.1 Business overview
7.14.2 Financial data
7.14.3 Product landscape
7.14.4 Strategic outlook
7.15 Volpara Solutions
7.15.1 Business overview
7.15.2 Financial data
7.15.3 Product landscape
7.15.4 Strategic outlook